{"name":"CAMP4 Therapeutics Corporation","slug":"camp4-therapeutics-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxQWkM3QkM1MEtLMWw0U2c4S3JiTXpmdWhFRXN1b0cxTGRwbGJ0TnpmMHgzZkI3dThSRzdGZ0M5WFlBTUFUdk5uNDZYbHdUX0ZETUM2Z3pMbUJ5Q1gzSG81cmw3b1FHM3FteHNYMlRMbmR0TFlXNjc4WDg1UDNWMmN3bEEwT1VOMUdMbjhLTmdpTUM0Q0VBSzB1Y29nQnVKYzlManhyZ1RwYlBwWHVJNWJoWmFFTG1nZ2xGZy0wUkxOcmNQUGkxVklKRWpzUHNHb2xGY2M4bXB1M1poSUZMMjl3YU9R?oc=5","date":"2026-03-25","type":"deal","source":"The Globe and Mail","summary":"Cantor Fitzgerald Sticks to Their Buy Rating for Surrozen (SRZN) - The Globe and Mail","headline":"Cantor Fitzgerald Sticks to Their Buy Rating for Surrozen (SRZN)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBGY3BfUlRWMlN0YW16NVM2V2NSYkJvcmhLUzBKM25PNmN4QjlUcU9CYm1iLVBjczgxRWptWUVLb2NWaHpUWmNmVXY3WFhuNktGX3NlX0ZybG9VeWxZRWdWeEpvTlF4aWRscHhGRm1B?oc=5","date":"2026-03-22","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in Camp4 Therapeutics Corp. (CAMP) - Stock Titan","headline":"If You Invested $1,000 in Camp4 Therapeutics Corp. (CAMP)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAJBVV95cUxNeVRrUENZd2tBTHR3SHNSSndHam5QOHpYRHVqNE1MRFF5cHdDSS1sWnA0UVJWNGRlWHl1UUdCVDN2TVVrV1RRYko5OGZOV0p4bTFXNnB5dUUxRGozQkVoa0dZcnMtYWlsZW9xUGdXY2tqRTlQUFpXTGdxZl95Tm9yOTB0VHlwckd6R1JKWUpfZ3BDc25vai12ajVDZF8xb1hvQ3J0bVB2UUFCb0dDLUg4eWJ0MHI3dlYweVRZWFpzbnNyNlhzSS1NRU9qVlQ1YkU2OWU4Q0J5SWhpdjFacERVV3A5UThCOUh3S0JUNzlteF9vbVFjd3EyYlFlTUxmRjk1NjhaMkNwYzRvSktnVUxxZQ?oc=5","date":"2026-03-04","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Are Bullish on These Healthcare Stocks: Rocket Pharmaceuticals (RCKT), Option Care Health (OPCH) - The Globe and Mail","headline":"Analysts Are Bullish on These Healthcare Stocks: Rocket Pharmaceuticals (RCKT), Option Care Health (OPCH)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxQbHNGdHg5QWNheHRlaXlXNWl4MzE2cndjbnBPSE50RUQ3Z1l6dW9GdnpScHdqRWt6QTZCLUlIUl92OEE5MXd3N0ZlRWdZaUpNOE9QdjVGZzJxNXhGZjc0b1V6VmdhVW8yT0U4cW9WT2o5d2t4RkRsdXdyR0JEVWJjd1dvdUdQT0hJcVhJbVBiMVBteUZhNkFVZnNPWm8yUmk2a2hFeDVLUzZyMzQ5MVBrNE9PLXM2MWZtMUZMaFY1c3lTbEstcjlVckpmcTJidWI3UU5pNTlweUw1TGZ6dFJONU5CQk8tVWhKTDZJUV9CaTdsMS03LWdSLUJiSU94T3piYk9MbmFPNi1YZDg?oc=5","date":"2026-01-09","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Offer Insights on Healthcare Companies: Entrada Therapeutics Inc (TRDA) and Xencor (XNCR) - The Globe and Mail","headline":"Analysts Offer Insights on Healthcare Companies: Entrada Therapeutics Inc (TRDA) and Xencor (XNCR)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPT1FqLWk1bmpZLXotWm9QYm92UnRoSDlKNGNEMHZ3RmMzRjAzTm5meThtbjl6a0lQWHRELWxtVVBVY2dvSzRfOWQtNFFobGswcUxQbTQxMkctZURZNUtvYjdMa3JTRkxOcmFHazNWM1Z0M0Rxb0t6TWFOeTFjVGJGMmpXWVkwaFFxU0dBTUVGTTE5VXhLcm04?oc=5","date":"2025-12-18","type":"regulatory","source":"Fierce Biotech","summary":"GSK pays $17.5M for CAMP4 regulatory RNA deal - Fierce Biotech","headline":"GSK pays $17.5M for CAMP4 regulatory RNA deal","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-10","type":"pipeline","source":"simplywall.st","summary":"After losing 46% in the past year, Camp4 Therapeutics Corporation (NASDAQ:CAMP) institutional owners must be relieved by the recent gain - simplywall.st","headline":"After losing 46% in the past year, Camp4 Therapeutics Corporation (NASDAQ:CAMP) institutional owners must be relieved by","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQU2lQYUlGSUd6SUtmTUgwX19KYV8tcGtTdV9fdW5TNHJiSlF1Z2FmbkYxWnVkZEx1Ri1tUHRXQU90bDFPLUZqdTNjUDdLMGl6MkZYTjI5NEVVVGc3RGhFMmVZWUFHT2I3UlozeExFM1F6d1NpV2k0Y25rRTNIS2pUR3JGdjdoZGtSb21NVnpQa1MyZTdZOXIwV0pBRnpab0QzSGxBODRURGRoUmF2QjFLcXdSUTM?oc=5","date":"2025-11-07","type":"pipeline","source":"Fierce Biotech","summary":"Sana, CAMP4 ditch clinical-stage assets for more promising preclinical candidates - Fierce Biotech","headline":"Sana, CAMP4 ditch clinical-stage assets for more promising preclinical candidates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxNczRCVnRTMEZHSXNtT18xU2NhZHdHdEZJWkIwdlZBaFFuQnphZ1c5S19UOU9BX2V1dk9KWGhMUHo2eUQ1d1F6aFVpT0xEb1E5eVh6Qm9tQXhhdW43empxTTdfd1VFUDNuTXdCVXhZUjJTMFlHUHgxWk5lSzVpcjFwTS11dWJnd3NBWXVZa1dWeXdMVnFTUmQ1REpnWG5rZENjX2R4bTBhUTBSTFJGOVZaaXhNNVpWN3RBeHhTeVRmdXUyYkI5R2tzSmlKZEliSXlISHJBck1lcFdJM0JySldOd0pmclVDRkZERTFXVXdub29fTGZTREU1U0hwQUZfUU9G?oc=5","date":"2025-09-15","type":"pipeline","source":"Citeline News & Insights","summary":"Finance Watch: LB Pharmaceuticals Launches Second-Largest Biopharma IPO Of 2025 In The US - Citeline News & Insights","headline":"Finance Watch: LB Pharmaceuticals Launches Second-Largest Biopharma IPO Of 2025 In The US - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPTzhuWjltcjFxQ0RsN1pGeWNBOXJlRU1CdWtUUmdDNmdvTmVmNTlGanVTU3BpTWlGUUJ3cmt4aGYzTkdSeF9tYkRhWk1fS09UNzFIMTF1UkpSVnprYjlIYjhZMi0xbjdBdHlBN3lyanhTS202dEtEbXpEcWt6TUNTemZyQUtCbk5iQXo5YjgzMWk2cWRoNG1GX3pXc2NxYkQ3alhkYndSOEtTdw?oc=5","date":"2025-09-10","type":"pipeline","source":"The Pharma Letter","summary":"CAMP4 soars on planned private placement of up to $100 million - The Pharma Letter","headline":"CAMP4 soars on planned private placement of up to $100 million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxQZ3k3OTZDUEFFcmxENWFIWkQzaFAxdEpQM01oOVJLLU5lSWZhQUZORWlLbGtlTEp0SVk4cTZLSW5oMllHa2ZhY1pLUXhTZGdVU1NtcnExV1BrMTFsRUFOQlRuZVEtQmdwWjUzMWpWdG9PUzFYaEd2OUUwblYtbDRvd193Yl9kRnFycE1MQnVld19IMFpobktURWRWTUFfZzN5eGh1ODJhX19ZcjJ6YzN0WEdidm81ZUJTc1Uyb08tc2lDRDBrSjRGdWVDSDN4aVlFZWFDSEM1cXhhS2pZVGh0TWF4T2MyTEg4T2UzYXp0TTJBZGZ0bk1leFpvdFZCVnJWb0R1SEVKaG1IekRjYk1QdHJIZ3k3SndPQTRpRlFmalN4VWs?oc=5","date":"2024-10-01","type":"deal","source":"GlobeNewswire","summary":"CAMP4 Enters Strategic Research Collaboration to Advance - GlobeNewswire","headline":"CAMP4 Enters Strategic Research Collaboration to Advance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOX1lDVXA4ZW5zcVk0ZGEwZHAzQkI4bHA3M1hHdk9CMlo2QXRnMllPaDU4UXB2c1VHUW1LcmsyekVlSHhKUnpybXQ0MVkzbW9FcEF0dUNRUk5ncTFPcUtxN2ltNUJ3ZlJlZmlNQ2UxSzJVbm5pQV9tUkFfMWZ5WWdZSFloTmprdFB2Z3diNTBuRFJvWGJhVXB6V1dBV1hhZw?oc=5","date":"2024-10-01","type":"pipeline","source":"Seeking Alpha","summary":"Camp4 Therapeutics Targets IPO On Early Positive Results (CAMP) - Seeking Alpha","headline":"Camp4 Therapeutics Targets IPO On Early Positive Results (CAMP)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNYVBwRnQyVDVNak1PN1c5S0loZVBSZUR3bzdVYmhBNDhFM093dFg5dTNoOGxXLTl3bG9JLWlibmRZX21FTlloek84aVViMHphRjBvc0JkQjBGQTVZajFOLTh6UXBkd0tOVDQ4M283Zlptd20tRzNKSktod0pUd091Z0x2enpxZm9XT1hsenVrZm5TazM4MERMUEJVM1QwSC1qcnprQ1Fzb2FOdw?oc=5","date":"2024-09-23","type":"deal","source":"The Business Journals","summary":"Biogen, Alnylam-partnered Camp4 Therapeutics unveils IPO plans - The Business Journals","headline":"Biogen, Alnylam-partnered Camp4 Therapeutics unveils IPO plans","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}